Flow diverter vs. stent-assisted coiling for unruptured wide-neck brain aneurysms
Official title: Traditional Approach Versus Flow Diverter for Unruptured Intracranial Wide-neck Bifurcation Aneurysms: a Prospective International Multicenter Randomized Controlled Study (FD-BWA Study)
Run by Nanfang Hospital, Southern Medical University · NCT07707076 · Data updated 2026-11-12
This trial tests whether a flow diverter (Pipeline) is safer or more effective than the traditional stent-assisted coiling for unruptured wide-neck bifurcation brain aneurysms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 266 (estimated) |
| Sponsor | Nanfang Hospital, Southern Medical University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | February 10, 2026 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2030 |
| Registry record updated | July 16, 2026 |
| Trial ID | NCT07707076 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 with unruptured wide-neck bifurcation intracranial aneurysms suitable for either treatment option.
✕Probably not a fit
Patients with multiple aneurysms requiring different treatment or conditions increasing surgical risk may derive less benefit or be excluded from favorable outcomes.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with unruptured wide-neck bifurcation intracranial aneurysms are randomly assigned to receive either a flow diverter or stent-assisted coiling. The study compares complications, stroke or death within one year, and long-term imaging results at 1, 2, and 5 years to assess safety and durability. Outcomes include procedure-related events, medical problems during follow-up, and imaging-based cure or stability over time. The trial is conducted at several hospitals in China with international collaboration. Eligibility targets adults 18–75 without recent ruptures or severe comorbidity.
Why it matters
Potential benefit: If successful, the trial could clarify which approach offers better safety and sustained effectiveness for this aneurysm type.
How similar studies have gone: Previous experience with flow diverters and stent-assisted coiling supports both approaches; comparative data in this exact aneurysm subtype is being explored in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-75 years; 2. Diagnosis of unruptured intracranial, bifurcation, saccular, wide-neck aneurysm by DSA/CTA/MRA; 3. Patients who can understand the purpose of the trial, voluntarily participate and sign the informed consent form. Exclusion Criteria: 1. Patients with two or more multiple aneurysms that all require treatment within 1 year; 2. Concomitant cerebrovascular diseases such as arteriovenous malformation, moyamoya disease; 3. Ruptured aneurysms and narrow-neck aneurysms; 4. Patients who have had a stroke (cerebral hemorrhage, cerebral infarction) within the past 1 month; 5. Extremely poor clinical condition, modified Rankin Score ≥3; 6. Patients already scheduled for surgery/interventional procedure within 3 months; 7. Patients deemed unsuitable for interventional treatment by the investigator (e.g., no suitable vascular access, excessively tortuous vessels, difficulty delivering stent); 8. Patients unsuitable for anesthesia or endovascular surgery, such as major diseases of heart, lung, liver, spleen, kidney, brain tumors, severe active infections, disseminated intravascular coagulation, severe mental illness; 9. Patients unable to receive antiplatelet or anticoagulant therapy; 10. Patients who have had or may have severe reactions to contrast media precluding pre-treatment medication; 11. Patients with a definite history of allergy to cobalt-chromium, nickel-titanium alloy materials; 12. Participation in other drug or medical device clinical trials before enrollment without reaching the primary endpoint timeframe; 13. Pregnant or breastfeeding women; 14. Patient's life expectancy less than 12 months; 15. Investigator judges that the patient has poor compliance and cannot complete the study as required.
Where it's running
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Huibin Kang, MD
- Email: kanghuibindoctor@163.com
- Phone: +8602062787842
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biological mesh reinforcement for digestive tract reconstruction
This study tests whether inserting a biological mesh during alimentary tract reconstruction can reduce bleeding and complications after digestive surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
Associations Between Multidimensional Phenotypes and Growth and Development
This study tests how external phenotypic traits like fingerprints, foot shape, and facial features relate to musculoskeletal growth and development in adults and older youth.
-
College students' motor function profiling with a wrist device and traditional Chinese medicine constitution
This study tests whether a wrist-worn wearable, movement tests, and health data can comprehensively assess motor function in college students.
-
Dynamic risk prediction for severe blood cell suppression in nasopharyngeal cancer
This study tests a dynamic risk model to see if it can predict grade 3 or higher anemia, low platelets, or low white blood cells during systemic therapy for adults with nasopharyngeal cancer.
-
Plantar Stimulation and Whole-Body Vibration for Muscle Activation in Young Adults
This study tests how whole-body vibration, plantar stimulation on different parts of the foot, and a Baduanjin heel-raise affect lower-limb muscle activity in young adults with flat feet or normal feet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.